No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 9.000
- +0.040+0.45%
Close Jan 10 16:00 ET
- 9.070
- +0.070+0.78%
Post 20:01 ET
476.70MMarket Cap-4.33P/E (TTM)
9.110High8.770Low1.61MVolume9.000Open8.960Pre Close14.45MTurnover4.39%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High2.05P/B330.47MFloat Cap4.09052wk Low--Dividend TTM36.72MShs Float71.580Historical High--Div YieldTTM3.80%Amplitude3.350Historical Low8.961Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35
Stoke Therapeutics' Promising Potential: Buy Rating Backed by Strong Phase 3 Trial Design and Positive Early Results
Stoke Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Chardan Capital Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $24
Stoke Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk
Stoke Therapeutics Reports Alignment With Regulators for Dravet Syndrome Trial
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.